Cargando…
Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target
Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated. Yet, the activity of YAP-1 in ocular surface squamous neoplasia (OSSN) has not been determined. Here, we i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354641/ https://www.ncbi.nlm.nih.gov/pubmed/37476371 http://dx.doi.org/10.3389/fonc.2023.1213426 |
_version_ | 1785074970534084608 |
---|---|
author | Julius, Peter Siyumbwa, Stepfanie N. Maate, Fred Moonga, Phyllis Kang, Guobin Kaile, Trevor West, John T. Wood, Charles Angeletti, Peter C. |
author_facet | Julius, Peter Siyumbwa, Stepfanie N. Maate, Fred Moonga, Phyllis Kang, Guobin Kaile, Trevor West, John T. Wood, Charles Angeletti, Peter C. |
author_sort | Julius, Peter |
collection | PubMed |
description | Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated. Yet, the activity of YAP-1 in ocular surface squamous neoplasia (OSSN) has not been determined. Here, we investigate the relationship between YAP-1 overexpression and OSSN. Using a cross-sectional study design, we recruited 227 OSSN patients from the University Teaching Hospitals in Lusaka, Zambia. Immunohistochemistry was used to assess YAP-1 protein overexpression in tumor tissue relative to surrounding benign squamous epithelium. OSSN patient samples (preinvasive, n = 62, 27% and invasive, n = 165, 73%) were studied. One hundred forty-nine invasive tumors contained adjacent preinvasive tissue, bringing the total number of preinvasive lesions examined to 211 (62 + 149). There was adjacent benign squamous epithelium in 50.2% (114/227) of OSSN samples. Nuclear YAP- 1 was significantly overexpressed in preinvasive (Fisher’s (F): p <.0001, Monte Carlo (MC): p <.0001) and invasive (F: p <.0001, MC: p <.0001) OSSN in comparison to adjacent benign squamous epithelium when analyzed for basal keratinocyte positive count, staining intensity, expression pattern, and Immunostaining intensity-distribution index. YAP-1 expression did not differ between preinvasive and invasive OSSN (p >.05), keratinizing and non- keratinizing cancer (p >.05), or between T1/T2 and T3/T4 stages in invasive tumors (p >.05). However, grade 2 and 3 tumors had significantly stronger nucleus YAP-1 overexpression intensity than grade 1 tumors (F: p = .0078, MC: p = .0489). By immunohistochemistry, we identified significant overexpression (upregulation of YAP-1 protein expression) in preinvasive and invasive OSSN lesions compared to neighboring benign squamous epithelium. YAP-1 expression was significantly higher in poorly and moderately differentiated invasive squamous cancer than in well-differentiated carcinomas. Overexpression of YAP-1 within the margin of preinvasive and invasive OSSN, but not in the neighboring normal epithelium, indicates that it plays a role in the development and progression of OSSN. |
format | Online Article Text |
id | pubmed-10354641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103546412023-07-20 Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target Julius, Peter Siyumbwa, Stepfanie N. Maate, Fred Moonga, Phyllis Kang, Guobin Kaile, Trevor West, John T. Wood, Charles Angeletti, Peter C. Front Oncol Oncology Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated. Yet, the activity of YAP-1 in ocular surface squamous neoplasia (OSSN) has not been determined. Here, we investigate the relationship between YAP-1 overexpression and OSSN. Using a cross-sectional study design, we recruited 227 OSSN patients from the University Teaching Hospitals in Lusaka, Zambia. Immunohistochemistry was used to assess YAP-1 protein overexpression in tumor tissue relative to surrounding benign squamous epithelium. OSSN patient samples (preinvasive, n = 62, 27% and invasive, n = 165, 73%) were studied. One hundred forty-nine invasive tumors contained adjacent preinvasive tissue, bringing the total number of preinvasive lesions examined to 211 (62 + 149). There was adjacent benign squamous epithelium in 50.2% (114/227) of OSSN samples. Nuclear YAP- 1 was significantly overexpressed in preinvasive (Fisher’s (F): p <.0001, Monte Carlo (MC): p <.0001) and invasive (F: p <.0001, MC: p <.0001) OSSN in comparison to adjacent benign squamous epithelium when analyzed for basal keratinocyte positive count, staining intensity, expression pattern, and Immunostaining intensity-distribution index. YAP-1 expression did not differ between preinvasive and invasive OSSN (p >.05), keratinizing and non- keratinizing cancer (p >.05), or between T1/T2 and T3/T4 stages in invasive tumors (p >.05). However, grade 2 and 3 tumors had significantly stronger nucleus YAP-1 overexpression intensity than grade 1 tumors (F: p = .0078, MC: p = .0489). By immunohistochemistry, we identified significant overexpression (upregulation of YAP-1 protein expression) in preinvasive and invasive OSSN lesions compared to neighboring benign squamous epithelium. YAP-1 expression was significantly higher in poorly and moderately differentiated invasive squamous cancer than in well-differentiated carcinomas. Overexpression of YAP-1 within the margin of preinvasive and invasive OSSN, but not in the neighboring normal epithelium, indicates that it plays a role in the development and progression of OSSN. Frontiers Media S.A. 2023-07-05 /pmc/articles/PMC10354641/ /pubmed/37476371 http://dx.doi.org/10.3389/fonc.2023.1213426 Text en Copyright © 2023 Julius, Siyumbwa, Maate, Moonga, Kang, Kaile, West, Wood and Angeletti https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Julius, Peter Siyumbwa, Stepfanie N. Maate, Fred Moonga, Phyllis Kang, Guobin Kaile, Trevor West, John T. Wood, Charles Angeletti, Peter C. Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
title | Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
title_full | Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
title_fullStr | Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
title_full_unstemmed | Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
title_short | Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
title_sort | yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354641/ https://www.ncbi.nlm.nih.gov/pubmed/37476371 http://dx.doi.org/10.3389/fonc.2023.1213426 |
work_keys_str_mv | AT juliuspeter yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT siyumbwastepfanien yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT maatefred yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT moongaphyllis yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT kangguobin yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT kailetrevor yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT westjohnt yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT woodcharles yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget AT angelettipeterc yesassociatedprotein1overexpressioninocularsurfacesquamousneoplasiaapotentialdiagnosticmarkerandtherapeutictarget |